TechNavio today launched its report Global Tuberculosis Drugs Market 2011-2015 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”Currently, the Bacille Calmette-Guerin (BCG) vaccine is the only vaccine for Tuberculosis (TB). It is inconsistent in protecting against the adolescent or adult form of TB, particularly pulmonary or lung TB. Furthermore, the World Health Organization (WHO) is no longer recommending it for the treatment of TB in HIV-infected infants. A rich pipeline of new vaccines has emerged over the years with almost 15 TB vaccines entering clinical trials. Companies are more focused on developing effective vaccines against the spread of the TB infection. In developing countries, there is an increased focus on improving vaccine production capacity to address needs.”
According to the report, the emergence of multidrug-resistant TB (MDR-TB) and extensive drug-resistant TB (XDR-TB) strains along with increase in the number of other mutant and antibiotic-resistant TB strains is propelling the growth of the Global Tuberculosis Drugs market.
Further, the report discusses that one of the key challenges is the insufficient demand in developed countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-tuberculosis-drugs-market-2011-2015
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research report – Global Tuberculosis Drugs Market 2011-2015
